Attached files
| file | filename |
|---|---|
| 8-K - FORM 8-K - Ardea Biosciences, Inc./DE | a57780e8vk.htm |
| EX-99.1 - EX-99.1 - Ardea Biosciences, Inc./DE | a57780exv99w1.htm |
Exhibit 99.2
| Drug Candidate Event Date Gout Gout Gout RDEA594 Phase 2a - Cohort 2 Allopurinol Combo Results (Study 201) ? RDEA594 Febuxostat Combination Study Results (Study 105) ? RDEA594 Phase 2b Monotherapy Study Results (Study 202) ? RDEA594 Phase 2b Allopurinol Add-On Study Results (Study 203) 2H10 RDEA594 Renal Impairment Study Results (Study 204) ? RDEA594 Phase 1b Allopurinol combination (Study 110) ? RDEA594 Phase 1b Febuxostat combination (Study 111) ? Cancer Cancer Cancer RDEA119 MTD achieved in Phase 1 advanced cancer ? RDEA119 MTD achieved in Phase 1/2 sorafenib combination ? 38 |